Display options
Cite
Holoshitz N, Kavinsky CJ, Hijazi ZM. The Edwards SAPIEN Transcatheter Heart Valve for Calcific Aortic Stenosis: A Review of the Valve, Procedure, and Current Literature. Cardiol Ther. 2012;1(1):6doi: 10.1007/s40119-012-0006-8.
Holoshitz, N., Kavinsky, C. J., & Hijazi, Z. M. (2012). The Edwards SAPIEN Transcatheter Heart Valve for Calcific Aortic Stenosis: A Review of the Valve, Procedure, and Current Literature. Cardiology and therapy, 1(1), 6. https://doi.org/10.1007/s40119-012-0006-8
Holoshitz, Noa, et al. "The Edwards SAPIEN Transcatheter Heart Valve for Calcific Aortic Stenosis: A Review of the Valve, Procedure, and Current Literature." Cardiology and therapy vol. 1,1 (2012): 6. doi: https://doi.org/10.1007/s40119-012-0006-8
Holoshitz N, Kavinsky CJ, Hijazi ZM. The Edwards SAPIEN Transcatheter Heart Valve for Calcific Aortic Stenosis: A Review of the Valve, Procedure, and Current Literature. Cardiol Ther. 2012 Dec;1(1):6. doi: 10.1007/s40119-012-0006-8. Epub 2012 Oct 30. PMID: 25135160; PMCID: PMC4107442.
Copy Download .nbib Format: NLM
Share it on

Cardiol Ther. 2012 Dec;1(1):6. doi: 10.1007/s40119-012-0006-8. Epub 2012 Oct 30.

The Edwards SAPIEN Transcatheter Heart Valve for Calcific Aortic Stenosis: A Review of the Valve, Procedure, and Current Literature.

Cardiology and therapy

Noa Holoshitz, Clifford J Kavinsky, Ziyad M Hijazi

Affiliations

  1. Rush Center for Congenital and Structural Heart Disease, Rush University Medical Center, 1653 West Congress Parkway, Chicago, IL, 60612, USA.

PMID: 25135160 PMCID: PMC4107442 DOI: 10.1007/s40119-012-0006-8

Abstract

The Edwards SAPIEN™ transcatheter heart valve (Edwards Lifesciences LLC, Irvine, CA, USA) is approved by the US Food and drug administration for use in the aortic position in patients with severe aortic stenosis who are not surgical candidates. This approval was backed by data from the Placement of AoRTic TraNscathetER Valve (PARTNER) I clinical trial, which showed the valve to be superior to standard medical therapy in high-risk nonoperative patients in cohort B of the trial. Although insertion of the valve is considered to be very safe, stroke, major vascular complications, and conduction abnormalities are the most frequent procedural complications. A dedicated team of physicians trained in structural cardiac interventions, including two interventional cardiologists, an echocardiographer, and a cardiac surgeon, are involved in every case. Improvements in valve design and streamlining of the delivery system, as well as favorable long-term outcomes, will hopefully pave the way for wider patient use in the future.

References

  1. N Engl J Med. 2010 Oct 21;363(17):1597-607 - PubMed
  2. Catheter Cardiovasc Interv. 2011 Dec 1;78(7):977-84 - PubMed
  3. Eur Heart J. 1992 May;13(5):704-8 - PubMed
  4. Heart. 1999 Aug;82(2):143-8 - PubMed
  5. N Engl J Med. 2012 May 3;366(18):1705-15 - PubMed
  6. Interact Cardiovasc Thorac Surg. 2011 May;12(5):762-7 - PubMed
  7. N Engl J Med. 2012 May 3;366(18):1696-704 - PubMed
  8. Ann Thorac Surg. 2003 Jun;75(6):1856-64; discussion 1864-5 - PubMed
  9. J Am Coll Cardiol. 2011 Jul 19;58(4):445-55 - PubMed
  10. J Am Coll Cardiol. 2004 Feb 18;43(4):698-703 - PubMed
  11. J Am Coll Cardiol. 2011 Nov 15;58(21):2248-56 - PubMed
  12. Catheter Cardiovasc Interv. 2006 Aug;68(2):199-204 - PubMed
  13. J Am Coll Cardiol. 2011 Nov 8;58(20):2130-8 - PubMed
  14. Circulation. 2002 Dec 10;106(24):3006-8 - PubMed
  15. J Am Coll Cardiol. 2012 Aug 7;60(6):548-58 - PubMed
  16. J Am Coll Cardiol. 1993 Apr;21(5):1220-5 - PubMed
  17. Eur Heart J. 2005 Dec;26(24):2714-20 - PubMed
  18. JACC Cardiovasc Interv. 2011 Feb;4(2):228-34 - PubMed
  19. Eur Heart J. 2011 Jan;32(2):191-7 - PubMed
  20. JACC Cardiovasc Interv. 2012 Aug;5(8):858-65 - PubMed
  21. J Am Coll Cardiol. 2010 Mar 16;55(11):1080-90 - PubMed
  22. Catheter Cardiovasc Interv. 2011 Feb 15;77(3):435-8 - PubMed
  23. Ann Thorac Surg. 2009 Jul;88(1 Suppl):S23-42 - PubMed
  24. JACC Cardiovasc Interv. 2011 Aug;4(8):861-7 - PubMed
  25. J Am Coll Cardiol. 2012 Aug 7;60(6):483-92 - PubMed
  26. Circulation. 2011 Nov 1;124(18):1964-72 - PubMed
  27. Circulation. 2010 Apr 27;121(16):1848-57 - PubMed
  28. Circulation. 1968 Jul;38(1 Suppl):61-7 - PubMed
  29. Catheter Cardiovasc Interv. 2012 Jul 1;80(1):128-38 - PubMed
  30. J Am Coll Cardiol. 2006 Mar 21;47(6):1214-23 - PubMed
  31. Circulation. 2010 Jul 6;122(1):62-9 - PubMed
  32. Arch Mal Coeur Vaiss. 2006 Mar;99(3):195-200 - PubMed
  33. JACC Cardiovasc Interv. 2011 Jul;4(7):733-42 - PubMed
  34. Circulation. 1982 Nov;66(5):1105-10 - PubMed
  35. N Engl J Med. 2012 May 3;366(18):1686-95 - PubMed
  36. J Am Coll Cardiol. 2011 Nov 15;58(21):2196-209 - PubMed
  37. Eur Heart J. 1987 May;8(5):471-83 - PubMed
  38. Circulation. 1990 Jul;82(1):124-39 - PubMed
  39. Lancet. 2000 Oct 21;356(9239):1403-5 - PubMed
  40. N Engl J Med. 2011 Jun 9;364(23):2187-98 - PubMed
  41. Herz. 2009 Aug;34(5):347-56 - PubMed

Publication Types